Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.930
-0.020 (-1.03%)
At close: Apr 28, 2026, 4:00 PM EDT
1.870
-0.060 (-3.11%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Seer, Inc. Revenue
In the year 2025, Seer, Inc. had annual revenue of $16.58M with 16.99% growth. Seer, Inc. had revenue of $4.20M in the quarter ending December 31, 2025, with 5.03% growth.
Revenue (ttm)
$16.58M
Revenue Growth
+16.99%
P/S Ratio
6.57
Revenue / Employee
$133,694
Employees
124
Market Cap
108.89M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verrica Pharmaceuticals | 35.58M |
| Pyxis Oncology | 13.86M |
| Cibus | 3.64M |
| NeOnc Technologies Holdings | 39.99K |
| Genelux | 8.00K |
| Fractyl Health | 3.00K |
SEER News
- 1 day ago - Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group - GlobeNewsWire
- 4 days ago - The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc. - Business Wire
- 15 days ago - Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group - GlobeNewsWire
- 15 days ago - The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc. - Business Wire
- 19 days ago - Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples - GlobeNewsWire
- 4 weeks ago - Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries - GlobeNewsWire
- 7 weeks ago - Seer, Inc. Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 7 weeks ago - The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs - Business Wire